NIPRO Launches FDA-Cleared ELISIO-HX Dialyzer in U.S.
Osaka, Japan and Bridgewater, New Jersey, August 4, 2026 NIPRO CORPORATION, through its U.S.-based subsidiary NIPRO Medical Corporation, has...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Osaka, Japan and Bridgewater, New Jersey, August 4, 2026 NIPRO CORPORATION, through its U.S.-based subsidiary NIPRO Medical Corporation, has...
Cambridge, Massachusetts – August 4, 2026 Moderna, Inc. has announced the initiation of a Phase 1 clinical trial evaluating...
Plano, Texas & New York – August 3, 2026 Integer Holdings Corporation, one of the world’s largest medical device...
BENGALURU, Karnataka, India, July 29, 2026 Biocon Limited has announced that its Canadian subsidiary has received Health Canada Notice...
CAESAREA, Israel, July 29, 2026 IceCure Medical Ltd. has announced a significant development that could broaden the role of...
NEW CANAAN, Conn., July 28, 2026 FlyteHealth has achieved General Availability within the Centers for Medicare & Medicaid Services...
PLEASANTON, Calif., July 28, 2026 Aqua Medical, Inc. has achieved a major clinical milestone with the successful treatment of...
MONTEREY, Calif., July 29, 2026 Elevation Spine has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for Saber-C®...
MOUNTAIN VIEW, Calif., July 28, 2026 NeuroPace announced that the U.S. Food and Drug Administration (FDA) has informed the...
Irvine, Calif., July 27, 2026 Masimo, a Danaher company and global leader in patient monitoring technologies, has received U.S....
